Collaborators GBDCoD. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210. https://doi.org/10.1016/S0140-6736(17)32152-9.

Article  Google Scholar 

Heusch G. Myocardial ischemia: lack of coronary blood flow, myocardial oxygen supply-demand imbalance, or what? Am J Physiol Heart Circ Physiol. 2019;316(6):H1439–46. https://doi.org/10.1152/ajpheart.00139.2019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El Nasasra A, Zeymer U. Current clinical management of acute myocardial infarction complicated by cardiogenic shock. Expert Rev Cardiovasc Ther. 2021;19(1):41–6. https://doi.org/10.1080/14779072.2021.1854733.

Article  CAS  PubMed  Google Scholar 

Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357(11):1121–35. https://doi.org/10.1056/NEJMra071667.

Article  CAS  PubMed  Google Scholar 

Tahir M, Ali S, Zhang W, et al. Aloperine: a potent modulator of crucial biological mechanisms in multiple diseases. Biomedicines. 2022;10(4). https://doi.org/10.3390/biomedicines10040905.

Yang C, Yu Y, Wu F, et al. Vasodilatory effects of aloperine in rat aorta and its possible mechanisms. Chin J Physiol. 2018;61(5):293–301. https://doi.org/10.4077/CJP.2018.BAH609.

Article  CAS  PubMed  Google Scholar 

Manville RW, van der Horst J, Redford KE, et al. KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines. Proc Natl Acad Sci USA. 2019;116(42):21236–45. https://doi.org/10.1073/pnas.1907511116.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Wu F, Yao W, Yang J, et al. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2017;95:1161–8. https://doi.org/10.1016/j.biopha.2017.08.126.

Article  CAS  Google Scholar 

Mao Q, Guo F, Liang X, Wu Y, Lu Y. Aloperine activates the PI3K/Akt pathway and protects against coronary microembolisation-induced myocardial injury in rats. Pharmacology. 2019;104(1–2):90–7. https://doi.org/10.1159/000500761.

Article  CAS  PubMed  Google Scholar 

Hu Z, Li J, Liu Q, Manville RW, Abbott GW. The plant-derived alkaloid aloperine prevents ischemia/reperfusion injury-induced sudden cardiac death. FASEB J: Off Publ Fed Am Soc Exp Biol. 2023;37(7):e22999. https://doi.org/10.1096/fj.202300253R.

Article  CAS  Google Scholar 

Li C, Gao Y, Tian J, et al. Sophocarpine administration preserves myocardial function from ischemia-reperfusion in rats via NF-kappaB inactivation. J Ethnopharmacol. 2011;135(3):620–5. https://doi.org/10.1016/j.jep.2011.03.052.

Article  CAS  PubMed  Google Scholar 

Hu Z, Crump SM, Zhang P, Abbott GW. Kcne2 deletion attenuates acute postischemia/reperfusion myocardial infarction. Cardiovasc Res. 2016;110(2):227–37. https://doi.org/10.1093/cvr/cvw048.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schunk SJ, Floege J, Fliser D, Speer T. WNT-beta-catenin signaling - a versatile player in kidney injury and repair. Nat Rev Nephrol. 2021;17(3):172–84. https://doi.org/10.1038/s41581-020-00343-w.

Article  CAS  PubMed  Google Scholar 

Li Y, Wang G, Liu J, Ouyang L. Quinolizidine alkaloids derivatives from Sophora alopecuroides Linn: bioactivities, structure-activity relationships and preliminary molecular mechanisms. Eur J Med Chem. 2020;188:111972. https://doi.org/10.1016/j.ejmech.2019.111972.

Article  CAS  PubMed  Google Scholar 

Cui YR, Qu F, Zhong WJ, et al. Beneficial effects of aloperine on inflammation and oxidative stress by suppressing necroptosis in lipopolysaccharide-induced acute lung injury mouse model. Phytomed : Int J Phytother Phytopharmacol. 2022;100:154074. https://doi.org/10.1016/j.phymed.2022.154074.

Article  CAS  Google Scholar 

Fu X, Sun F, Wang F, et al. Aloperine protects mice against DSS-induced colitis by PP2A-mediated PI3K/Akt/mTOR signaling suppression. Mediat Inflamm. 2017;2017:5706152. https://doi.org/10.1155/2017/5706152.

Article  CAS  Google Scholar 

He W, Zhou H, He X. Aloperine protects beta-cells against streptozocin-induced injury to attenuate diabetes by targeting NOS1. Eur J Pharmacol. 2022;916:174721. https://doi.org/10.1016/j.ejphar.2021.174721.

Article  CAS  PubMed  Google Scholar 

Hu S, Zhang Y, Zhang M, et al. Aloperine protects mice against Ischemia-Reperfusion (IR)-Induced renal injury by regulating PI3K/AKT/mTOR signaling and AP-1 activity. Mol Med. 2016;21(1):912–23. https://doi.org/10.2119/molmed.2015.00056.

Article  CAS  PubMed  Google Scholar 

Li Z, Cao X, Xiao L, Zhou R. Aloperine protects against cerebral ischemia/reperfusion injury by activating the PI3K/AKT signaling pathway in rats. Exp Ther Med. 2021;22(4):1045. https://doi.org/10.3892/etm.2021.10478.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin W, Han J, Zhang Z, Han Z, Wang S. Aloperine protects mice against bleomycin-induced pulmonary fibrosis by attenuating fibroblast proliferation and differentiation. Sci Rep. 2018;8(1):6265. https://doi.org/10.1038/s41598-018-24565-y.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev. 2019;99(4):1765–817. https://doi.org/10.1152/physrev.00022.2018.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo Y, Zhang W, Zhou X, et al. Roles of ferroptosis in cardiovascular diseases. Front Cardiovasc Med. 2022;9:911564. https://doi.org/10.3389/fcvm.2022.911564.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng Y, Madungwe NB, Imam Aliagan AD, Tombo N, Bopassa JC. Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels. Biochem Biophys Res Commun. 2019;520(3):606–11. https://doi.org/10.1016/j.bbrc.2019.10.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan Z, Cai L, Wang S, Wang J, Chen B. Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis. Front Pharmacol. 2021;12:628988. https://doi.org/10.3389/fphar.2021.628988.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu S, Wu B, Zhong B, et al. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2)/System xc-/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered. 2021;12(2):10924–34. https://doi.org/10.1080/21655979.2021.1995994.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li T, Tan Y, Ouyang S, He J, Liu L. Resveratrol protects against myocardial ischemia-reperfusion injury by attenuating ferroptosis. Gene. 2022;808:145968. https://doi.org/10.1016/j.gene.2021.145968.

Article  CAS  PubMed  Google Scholar 

Guo X, Chen Y, Liu Q. Necroptosis in heart disease: molecular mechanisms and therapeutic implications. J Mol Cell Cardiol. 2022;169:74–83. https://doi.org/10.1016/j.yjmcc.2022.05.006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oerlemans MI, Liu J, Arslan F, et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol. 2012;107(4):270. https://doi.org/10.1007/s00395-012-0270-8.

Article  CAS  PubMed  Google Scholar 

Cao L, Mu W. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacol Res. 2021;163:105297. https://doi.org/10.1016/j.phrs.2020.105297.

Article  CAS  PubMed  Google Scholar 

Rose BA, Force T, Wang Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev. 2010;90(4):1507–46. https://doi.org/10.1152/physrev.00054.2009.

Article  CAS  PubMed  Google Scholar 

Rossello X, Yellon DM. The RISK pathway and beyond. Basic Res Cardiol. 2018;113(1):2. https://doi.org/10.1007/s00395-017-0662-x.

Article  CAS  PubMed  Google Scholar 

Cheng X, Li H, Yan Z, Liu J, Hu Z. Ischemic limb preconditioning-induced anti-arrhythmic effect in reperfusion-induced myocardial injury: is it mediated by the RISK or SAFE pathway? Pflugers Arch. 2022;474(9):979–91. https://doi.org/10.1007/s00424-022-02716-5.

Article  CAS  PubMed  Google Scholar 

Hu Z, Ju F, Du L, Abbott GW. Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death. Cardiovasc Diabetol. 2021;20(1):199. https://doi.org/10.1186/s12933-021-01392-6.

Article  CAS